Profile image
Research Associate

Dr Brendan Jacka

BSc (Hons)

MSc

PhD

Therapeutic and Vaccine Research Program
Phone
+61-2-9348 0772
E-mail
bjacka@kirby.unsw.edu.au
Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson D; Manandhar B; Klemm V; Tan H-X; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville S; Kent S; Byrne A; Brew B; Darley D; Dore G; Kelleher A; Matthews G, 2023, Improvement of immune dysregulation and health-related quality of life in individuals with long COVID at 24-months following SARS-CoV-2 infection, , http://dx.doi.org/10.1101/2023.08.27.23294704
2023
Jacka B; Goldman J; Yedinak J; Bernstein E; Hadland S; Buxton J; Sherman S; Biello K; Marshall BDL, 2020, A Randomised Clinical Trial of a Theory-Based Fentanyl Overdose Education and Fentanyl Test Strip Distribution Intervention to Reduce Rates of Opioid Overdose: Study Protocol for A Randomized Controlled Trial, , http://dx.doi.org/10.21203/rs.3.rs-45321/v1
2020
Jacka BP; Colleagues , Feasibility of hepatitis C virus testing and linkage in community supervision offices: Great potential but persistent challenges, , http://dx.doi.org/10.21428/cb6ab371.33a158b2
Nolen S; Wilson T; Jacka BP; Li Y; Beaudoin FL; Marshall BDL, 2023, 'Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose', Addictive Behaviors Reports, 17, pp. 100496, http://dx.doi.org/10.1016/j.abrep.2023.100496
2023
Weiss NH; Forkus SR; Raudales AM; Kiefer R; Thomas ED; Goldstein SC; Lin N; Samuels EA; Marshall BDL; Jacka BP, 2023, 'Emotion Dysregulation as a Risk Factor for Posttraumatic Stress Disorder Stemming from Opioid Overdose Responding Among Community Laypeople', International Journal of Mental Health and Addiction, http://dx.doi.org/10.1007/s11469-023-01063-5
2023
Ranney M; Marshall BDL; Langdon K; Wiehe S; Aalsma M; Jacka B; Peachey A; Beaudoin F, 2023, 'Increasing Peer Support for Opioid Use Disorder Recovery During COVID-19 Through Digital Health: Protocol for a National Randomized Controlled Trial', Iproceedings, 9, pp. e39424 - e39424, http://dx.doi.org/10.2196/39424
2023
Wunsch C; Wightman R; Pratty C; Jacka B; Hallowell BD; Clark S; Davis CS; Samuels EA, 2023, 'Thirty-day Treatment Continuation After Audio-only Buprenorphine Telehealth Initiation', Journal of Addiction Medicine, 17, pp. 206 - 209, http://dx.doi.org/10.1097/ADM.0000000000001077
2023
Jacka BP; Nolen S; Bessey SE; Zang X; Goedel WC; Yedinak JL; Marshall BDL, 2022, 'Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study', Journal of Acquired Immune Deficiency Syndromes, 91, pp. 449 - 452, http://dx.doi.org/10.1097/QAI.0000000000003093
2022
Macmadu A; Yolken A; Frueh L; Toussaint JR; Newman R; Jacka BP; Collins AB; Marshall BDL, 2022, 'Characteristics of events in which police responded to overdoses: an examination of incident reports in Rhode Island', Harm Reduction Journal, 19, pp. 116, http://dx.doi.org/10.1186/s12954-022-00698-2
2022
Beaudoin FL; Jacka BP; Li Y; Samuels EA; Hallowell BD; Peachey AM; Newman RA; Daly MM; Langdon KJ; Marshall BDL, 2022, 'Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial', JAMA network open, 5, pp. e2225582, http://dx.doi.org/10.1001/jamanetworkopen.2022.25582
2022
Jacka BP; Bazerman LB; Dickerson C; Moody M; Martin J; Patry E; Cady T; Compere H; Boudreau M; Beckwith CG, 2022, 'Feasibility of hepatitis C virus testing and linkage in community supervision offices: Great potential but persistent challenges', International Journal of Drug Policy, 103, http://dx.doi.org/10.1016/j.drugpo.2022.103668
2022
Jacka BP; Ziobrowski HN; Lawrence A; Baird J; Wentz AE; Marshall BDL; Wightman RS; Mello MJ; Beaudoin FL; Samuels EA, 2022, 'Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program', Academic Emergency Medicine, 29, pp. 294 - 307, http://dx.doi.org/10.1111/acem.14409
2022
Singleton AL; Marshall BDL; Bessey S; Harrison MT; Galvani AP; Yedinak JL; Jacka BP; Goodreau SM; Goedel WC, 2021, 'Network structure and rapid HIV transmission among people who inject drugs: A simulation-based analysis', Epidemics, 34, pp. 100426, http://dx.doi.org/10.1016/j.epidem.2020.100426
2021
Høj SB; Jacka B; Minoyan N; Bussière P; Bruneau J, 2021, 'Deconstructing the ‘cheque effect’: short-term changes in injection drug use after receiving income assistance and associated factors', Addiction, 116, pp. 571 - 582, http://dx.doi.org/10.1111/add.15192
2021
Wightman RS; Jacka B; Uber J; McKenzie M; Reddy NG; Winters R; Jordison Keeler LA; Samuels EA, 2021, 'Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation', American Journal of Emergency Medicine, 50, pp. 409 - 412, http://dx.doi.org/10.1016/j.ajem.2021.08.071
2021
Jacka BP; Janssen T; Garner BR; Yermash J; Yap KR; Ball EL; Hartzler B; Becker SJ, 2021, 'Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder', Drug and Alcohol Dependence, 221, pp. 108617, http://dx.doi.org/10.1016/j.drugalcdep.2021.108617
2021
Jacka B; Beaudoin F; Li Y; Nimaja E; Yedinak J; Samuels E; Marshall BDL, 2021, 'Objective Outcome Measures in Randomized Clinical Trials of Interventions to Reduce Risk of Opioid Overdose Following Discharge From the Emergency Department: Utility of Administrative Data Linkage', Journal of Addiction Medicine, 15, pp. 174 - 175, http://dx.doi.org/10.1097/ADM.0000000000000705
2021
Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA, 2021, 'Race, ethnicity, and emergency department post-overdose care', Journal of Substance Abuse Treatment, 131, http://dx.doi.org/10.1016/j.jsat.2021.108588
2021
Cho D; Jacka B; Marshall B; Beaudoin F, 2021, '239 Evaluating the Role of Recovery Capital on Willingness to Enter Treatment for Emergency Department Patients With Opioid Use Disorders', Annals of Emergency Medicine, 78, pp. S97 - S97, http://dx.doi.org/10.1016/j.annemergmed.2021.09.251
2021
Min S; Shin J; Jacka B; Bazerman L; Nijhawan AE; Beckwith C, 2021, '841. Survey of Current HIV and HCV Policies and Practices in Prisons and Jails Serving High-Risk Geographic Hotspots', Open Forum Infectious Diseases, 8, pp. S511 - S512, http://dx.doi.org/10.1093/ofid/ofab466.1037
2021
Jacka BP; Goldman JE; Yedinak JL; Bernstein E; Hadland SE; Buxton JA; Sherman SG; Biello KB; Marshall BDL, 2020, 'A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial', Trials, 21, http://dx.doi.org/10.1186/s13063-020-04898-8
2020
Jacka B; Larney S; Degenhardt L; Janjua N; Høj S; Krajden M; Grebely J; Bruneau J, 2020, 'Prevalence of injecting drug use and coverage of interventions to prevent HIV and hepatitis C virus infection among people who inject drugs in Canada', American Journal of Public Health, 110, pp. 45 - 50, http://dx.doi.org/10.2105/AJPH.2019.305379
2020
Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K; Grebely J; Applegate T; Read P; Hajarizadeh B; Ezard N; Dore G; Edwards M, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233
2020
Jacka BP; Phipps E; Marshall BDL, 2020, 'Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs', International Journal of Drug Policy, 83, pp. 102895, http://dx.doi.org/10.1016/j.drugpo.2020.102895
2020
Picard J; Jacka B; Høj S; Laverdière É; Cox J; Roy É; Bruneau J, 2020, 'Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs', AIDS and Behavior, 24, pp. 2400 - 2408, http://dx.doi.org/10.1007/s10461-020-02800-w
2020
Gaur DS; Jacka BP; Green TC; Samuels EA; Hadland SE; Krieger MS; Yedinak JL; Marshall BDL, 2020, 'US drug overdose mortality: 2009–2018 increases affect young people who use drugs', International Journal of Drug Policy, 85, http://dx.doi.org/10.1016/j.drugpo.2020.102906
2020
Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L, 2020, 'Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia', Substance Abuse, 41, pp. 139 - 145, http://dx.doi.org/10.1080/08897077.2019.1635954
2020
Artenie AA; Minoyan N; Jacka B; Høj S; Jutras-Aswad D; Roy É; Gauvin L; Zang G; Bruneau J, 2019, 'Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs', CMAJ, 191, pp. E462 - E468, http://dx.doi.org/10.1503/cmaj.181506
2019
Makarenko I; Artenie A; Hoj S; Minoyan N; Jacka B; Zang G; Barlett G; Jutras-Aswad D; Martel-Laferriere V; Bruneau J, 2019, 'Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?', International Journal of Drug Policy, 72, pp. 69 - 76, http://dx.doi.org/10.1016/j.drugpo.2019.04.002
2019
Høj SB; Jacka B; Minoyan N; Artenie AA; Bruneau J, 2019, 'Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs', International Journal of Drug Policy, 72, pp. 11 - 23, http://dx.doi.org/10.1016/j.drugpo.2019.04.001
2019
Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J, 2019, 'Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada', Journal of Viral Hepatitis, 26, pp. 1413 - 1422, http://dx.doi.org/10.1111/jvh.13194
2019
Jacka B; Kemp R; Degenhardt L; Peacock A; Clare P; Bruno R; Dev A; Sotade O; Larance B, 2019, 'Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007–2015', Drug and Alcohol Review, 38, pp. 159 - 168, http://dx.doi.org/10.1111/dar.12908
2019
Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, 22, pp. e25222, http://dx.doi.org/10.1002/jia2.25222
2019
Catlett B; Lamoury FMJ; Bajis S; Hajarizadeh B; Martinez D; Mowat Y; Cunningham PH; Jacka BP; Cloherty GA; Marks P; Dore GJ; Grebely J; Applegate TL, 2019, 'Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study', Journal of Viral Hepatitis, 26, pp. 1423 - 1430, http://dx.doi.org/10.1111/jvh.13196
2019
Jacka B; Bray BC; Applegate TL; Marshall BDL; Lima VD; Hayashi K; DeBeck K; Raghwani J; Harrigan PR; Krajden M; Montaner JSG; Grebely J, 2018, 'Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach', Journal of Viral Hepatitis, 25, pp. 28 - 36, http://dx.doi.org/10.1111/jvh.12758
2018
Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B, 2018, 'Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users', Drug and Alcohol Review, 37, pp. 664 - 670, http://dx.doi.org/10.1111/dar.12688
2018
Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe AYM; Miller V; Ceccherini-Silberstein F; Bull RA; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky JM; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review', Hepatology Communications, 1, pp. 379 - 390, http://dx.doi.org/10.1002/hep4.1050
2017
Bartlett SR; Applegate T; Jacka B; Lamoury F; Bull R; Danta M; Bradshaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2017, 'P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015', Journal of Virus Eradication, 3, pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30747-0
2017
Jacka B; Peacock A; Degenhardt L; Bruno R; Clare P; Kemp R; Dev A; Larance B, 2017, 'Trends in PIEDs use among male clients of needle–syringe programs in Queensland, Australia; 2007–2015', International Journal of Drug Policy, 46, pp. 74 - 78, http://dx.doi.org/10.1016/j.drugpo.2017.05.048
2017
Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection, Genetics and Evolution, 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028
2016
Jacka B; Applegate T; Poon AF; Raghwani J; Harrigan PR; Debeck K; Milloy MJ; Krajden M; Olmstead A; Joy JB; Marshall BDL; Hayashi K; Pybus OG; Lima VD; Magiorkinis G; Montaner J; Lamoury F; Dore GJ; Wood E; Grebely J, 2016, 'Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada', Journal of Hepatology, 64, pp. 1247 - 1255, http://dx.doi.org/10.1016/j.jhep.2016.02.031
2016
Bradshaw D; Raghwani J; Jacka B; Sacks-Davis R; Lamoury F; Down I; Prestage G; Applegate TL; Hellard M; Sasadeusz J; Dore GJ; Pybus OG; Matthews GV; Danta M, 2016, 'Venue-based networks may underpin HCV transmissions amongst HIV-infected gay and bisexual men', PLoS ONE, 11, pp. e0162002, http://dx.doi.org/10.1371/journal.pone.0162002
2016
Montoya V; Olmstead A; Tang P; Cook D; Janjua N; Grebely J; Jacka B; Poon AFY; Krajden M, 2016, 'Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencing', Infection, Genetics and Evolution, 43, pp. 329 - 337, http://dx.doi.org/10.1016/j.meegid.2016.06.015
2016
Lamoury FMJ; Bartlett S; Jacka B; Hajarizadeh B; Grebely J; Matthews GV; Dore GJ; Applegate TL, 2015, 'Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types', Journal of Molecular Diagnostics, 17, pp. 583 - 589, http://dx.doi.org/10.1016/j.jmoldx.2015.05.003
2015
Olmstead AD; Joy JB; Montoya V; Luo I; Poon AFY; Jacka B; Lamoury F; Applegate T; Montaner J; Khudyakov Y; Grebely J; Cook D; Harrigan PR; Krajden M, 2015, 'A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events', Infection, Genetics and Evolution, 33, pp. 101 - 109, http://dx.doi.org/10.1016/j.meegid.2015.04.017
2015
Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J; Dore GJ; Applegate TL, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', PLoS ONE, 10, pp. e0131437, http://dx.doi.org/10.1371/journal.pone.0131437
2015
Cunningham EB; Jacka B; DeBeck K; Applegate TL; Harrigan PR; Krajden M; Marshall BDL; Montaner J; Lima VD; Olmstead AD; Milloy MJ; Wood E; Grebely J, 2015, 'Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada', Drug and Alcohol Dependence, 152, pp. 272 - 276, http://dx.doi.org/10.1016/j.drugalcdep.2015.04.005
2015
Jacka B; Applegate T; Krajden M; Olmstead A; Harrigan PR; Marshall BDL; Debeck K; Milloy MJ; Lamoury F; Pybus OG; Lima VD; Magiorkinis G; Montoya V; Montaner J; Joy J; Woods C; Dobrer S; Dore GJ; Poon AFY; Grebely J, 2014, 'Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada', Hepatology, 60, pp. 1571 - 1580, http://dx.doi.org/10.1002/hep.27310
2014
Jacka B; Lamoury F; Simmonds P; Dore GJ; Grebely J; Applegate T, 2013, 'Sequencing of the Hepatitis C Virus: A Systematic Review', PLoS ONE, 8, pp. e67073, http://dx.doi.org/10.1371/journal.pone.0067073
2013
Baleriola-Lucas C; Johal H; Jacka B; Whybin R; Taylor PCA; Rawlinson WD; robertson P, 2012, 'Infectious disease screening of blood specimens collected post-mortem provides comparable results to pre-mortem specimens', Cell and Tissue Banking, 13, pp. 251 - 258, http://dx.doi.org/10.1007/s10561-011-9252-6
2012
Baleriola C; Johal H; Jacka B; Chaverot S; Bowden S; Lacey S; Rawlinson WD, 2011, 'Stability of HCV, HIV and HBV nucleic acid in plasma samples after long-term storage at -20°C and -70°C', Journal of Clinical Microbiology, 49, pp. 3163 - 3167
2011
Dolan K; Larney S; Jacka B; Rawlinson WD, 2009, 'Presence of hepatitis C virus in syringes confiscated in prisons in Australia', Journal of Gastroenterology and Hepatology, 24, pp. 1655 - 1657
2009
Artenie AA; Minoyan N; Jacka B; Hoj S; Roy E; Jutras-Aswad D; Bruneau J, 2018, 'Perceived adequacy of opiate agonist therapy dosage is associated with risk of hepatitis C virus infection among people who inject drugs: examining the role of flexible, patient-centered approaches in HCV prevention', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, pp. 180 - 181, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000307&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Lamoury F; Bajis S; Martinez D; Mowat Y; Jayasinghe I; Martinez M; Cunningham P; Catlett B; Jacka B; Marks P; Grebely J; Cloherty G; Dore G; Applegate T, 2018, 'Evaluation of a hepatitis C virus core antigen assay in dried-blood spots: a cohort study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S317 - S318, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30854-7
2018
Jacka B; Roy E; Hoj S; Zang G; Minoyan N; Jutras-Aswad D; Bruneau J, 2018, 'Same-sex behaviour and its association with HCV acquisition in a cohort of people who inject drugs', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, pp. 150 - 150, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000254&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Bradshaw D; Jacka B; Sacks-Davis R; Lamoury F; Applegate T; Dore G; Down I; Luciani F; Hellard M; Sasadeusz J; Danta M; Matthews G, 2014, 'A novel method comparing sexual networks with the HCV phylogeny in HIV-positive MSM with acute HCV infection identifies two potential intervention targets for permucosally transmitted HCV in Australia', in HIV MEDICINE, WILEY-BLACKWELL, pp. 136 - 136
2014
Olmstead A; Montoya V; Joy J; Luo I; Janjua NZ; Poon A; Jacka B; Lamoury F; Applegate TL; Grebely J; Harrigan R; Krajden M, 2014, 'Molecular sequencing and phylogenetics as enhanced surveillance tools for monitoring Hepatitis C virus transmission dynamics in British Columbia', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 283A - 283A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483801103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Jacka B; Poon A; Applegate TL; Krajden M; Olmstead A; Harrigan R; Marshall BD; DeBeck K; Milloy M-J; Lamoury F; Pybus O; Lima V; Magiorkinis G; Montoya V; Montaner J; Joy J; Dore GJ; Kerr T; Wood E; Grebely J, 2014, 'Hepatitis C virus network dynamics among people who inject drugs in Vancouver, Canada', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 907A - 908A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014
2014
Jacka B; Applegate T; Poon AF; Harrigan R; Dore GJ; Olmstead A; DeBeck K; Milloy M-J; Lamoury F; Woods C; Brumme Z; Dobrer S; Lima VD; Montaner J; Joy J; Marshall BD; Kerr T; Wood E; Krajden M; Grebely J, 2014, 'P762 TEMPORAL CHANGES IN HEPATITIS C VIRUS GENOTYPE 3A DISTRIBUTION AMONG PEOPLE WHO INJECT DRUGS IN VANCOUVER, CANADA', in Journal of Hepatology, Elsevier, ENGLAND, London, pp. s324 - s325, presented at 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, ENGLAND, London, 09 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/s0168-8278(14)60923-5
2014
Bradshaw D; Jacka B; Sacks-Davis R; Lamoury F; Applegate TL; Dore GJ; Down I; Luciani F; Hellard M; Sasadeusz J; Danta M; Matthews G, 2013, 'A novel method comparing sexual networks with the HCV phylogeny in HIV-positive men who have sex with men (MSM) with acute HCV infection identifies two potential intervention targets for permucosally-transmitted HCV', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 1307A - 1307A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, DC, Washington, 01 November 2013 - 05 November 2013
2013
Jacka B; Lamoury F; Simmonds P; Dore GJ; Grebely J; Applegate T, 2013, 'SEQUENCING THE HEPATITIS C VIRUS: A SYSTEMATIC REVIEW', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S471 - S472, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)61160-5
2013
Jacka B; Larney S; Hoj S; Degenhardt L; Krajden M; Janjua N; Grebely J; Bruneau J, 2018, 'Estimating the number of people who inject drugs and the coverage of harm reduction services in Canada', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, Vol. 25, pp. 131 - 131, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe A; Miller V; Bull RA; Ceccherini-Silberstein F; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky J-M; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S323 - S323, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30970-4
2017
Olmstead AD; Montoya V; Joy J; Poon AF; Jacka B; Lamoury F; Applegate T; Monaner J; Khudyakov Y; Grebely J; Cook D; Harrigan PR; Krajden M, 2015, 'Characterizing hepatitis C virus transmission dynamics using molecular phylogenetic-based methods', GERMANY, Berlin, Vol. 22, pp. 60 - 60, presented at 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), GERMANY, Berlin, 26 June 2015 - 28 June 2015, http://dx.doi.org/10.1111/jvh.76_12425
2015
  • Clinical & public health epidemiology
  • New models of care, including point of care diagnostics and patient navigator protocols
  • Randomized clinical trials, observational studies, public health surveillance
  • Trauma and distress among professional and layperson first responders
  • Prevention, treatment and epidemiology of substance use and substance use disorder in North America
  • Novel psychoactive drugs and contaminated drug supply
  • Harm reduction
  • Access to healthcare for vulnerable or minoritized communities